Diapositive 1

advertisement
Regulation of hepatic Fatty Acid Synthase
properties by O-GlcNAcylation in vivo and ex vivo
S/T
Baldini Steffi, Anne-Marie Mir, Marlène Mortuaire, Céline Guinez and Tony Lefebvre
CNRS-UMR 8576, Unit of Structural and Functional Glycobiology, FRABio FR3688, Lille 1
University, 59655 Villeneuve d’Ascq, France
Control of blood glucose by the liver
Fasted
A l’état nourri
gluco-dependent organs
glucose
glycogenolysis
gluconeogenesis
β-oxydation
Fatty Acid
+
glucagon
adipocytes
pancreas
Hepatic glucose production
Control of blood glucose by the liver
Fasted
In the fed state
gluco-dependent organs
Glucose absorption
glucose
glucose
glycogenolysis
gluconeogenesis
β-oxydation
Fatty Acid
+
glucagon
adipocytes
glycogenogenesis
glycolysis
lipogenesis
VLDL
+
insulin
adipocytes
pancreas
Hepatic glucose production
pancreas
Hepatic glucose uptake
Dysregulation of glucido-lipidic metabolism
and hepatic steatosis
The fat represents at least 5 to
10% of the liver weight
15% no obese
65% obèse (IMC 30-40)
1/3
3% no obese
20% obese
10 à 29%
4 à 27%
CHC
The causes of hepatic steatosis
Glucose
Food
chylomicrons
VLDL
Lipogenesis
TG
Fatty
Acids
esterification
Lipolysis
Adipose tissue
Supply
Lipolysis
Lipogenesis de novo
Food
STEATOSIS
The causes of hepatic steatosis
Glucose
Food
Lipogenesis
TG
chylomicrons
-oxydation
Fatty
Acids
esterification
VLDL
Lipolysis
Secretion
Adipose tissue
Supply
Lipolysis
Lipogenesis de novo
Food
STEATOSIS
Use
-oxydation
Secretion
The causes of hepatic steatosis
Glucose
Food
Lipogenesis
14%
26%
TG
chylomicrons
-oxydation
Fatty
Acids
esterification
VLDL
59%
Lipolysis
Secretion
Adipose tissue
Supply
Lipolysis
Lipogenesis de novo
Food
STEATOSIS
Use
-oxydation
Secretion
Donnelly et al., 2005
Hepatic steatosis : Fatty acids of triglycerides come from
59% of the lipolyse
26% of the lipogenesis
14 % of the food
Lipogenesis and Fatty Acid Synthase
Lipogenesis
Glucose
ACC : AcetylCoA Carboxylase
GLUT
Glucose
CYTOSOL
Citrate
Acetyl-CoA
Glucose-6-P
Pyruvate
Pyruvate
ACC
Malonyl-CoA
FAS
Acyl-CoA
MITOCHONDRIA
Acetyl-CoA
Citrate
Fatty Acid Synthase
Malonyl/acetyl
transferase
Triglycerides
β-ketoacyl-synthase
β-hydroxyacyl
dehydratase
Enoyl reductase
β-ketoacyl-reductase
• 2 subunits
• 7 activities
• liver, adipose tissue, mammary gland
ACP
Thioesterase
Overall reaction : acetylCoA + 7 malonylCoA + 14 NADPH,H+  palmitoylCoA (C16:0) + 7CO2 + 14 NADP++ 7CoA
Regulation of FAS
 At the transcriptional level by the transcription factors,ChREBP and SREBP-1c
insulin
glucose
glucose
+
ChREBP
SREBP-1c
insulin
+
Glycolysis
G6P
PEP
L-PK
+
Pyruvate
+
citrate
+
ACC, FAS,
SCD-1
FA
Lipogenesis
Hepatocytes
 At the post translational level by phosphorylation
Functions of O-GlcNAcylation
… Hundreds proteins bearing O-GlcNAc have been identified
Enzymes of metabolism
Kinases/phosphatases
Proteins of stress
Transcription Factors
Proteins of cytoskeleton
Proteasome
Proteins of pore nuclear
Ribosomals proteins
… Involved in many cellular processes
Translation
Cell cycle
Apoptosis
Cell trafficking
Transcription
Signaling
Development
Proteins
degradation
Cellular architecture
… dynamism disturbed in certain
diseases
Neurological
diseases
Type 2 diabetes
Cancers
Cardiovascular diseases
OGT/OGA
O-N-acetylglucosaminylation (O-GlcNAcylation)
O-GlcNAcylation
UDP
UDP-GlcNAc
ATP
ADP
OH
OGT (O-GlcNAc transferase)
S/T
Kinase
S/T
OGA (O-GlcNAcase)
H2 O
S/T
Phosphatase
Pi
GlcNAc
H2O
The Hexosamine Biosynthesis Pathway (HBP)
Glc
Glc
G6P
F6P
GFAT
Gln Glu
GlcNH26P
GlcNH26P
AcT
Acetyl
CoA
GlcNAc6P
HSCoA
UDP-GlcNAc
PPase
GlcNAc1P
UTP
PPi
UDPGlcNAc
Hypothesis
• FAS expression and O-GlcNAcylation level depend on glucose concentrations
Relation between O-GlcNAcylation, expression and activity of FAS
 Is FAS O-GlcNAcylated ?
 Relations between FAS O-GlcNAcylation and nutritional conditions
 Do O-GlcNAcylation levels interfere with:
 FAS expression
 FAS activity
 FAS stabilization
O-GlcNAcylation levels and FAS expression
in physiopathological models
Model 1 : Use of mice C57BL6 wild type or ob/ob
Day
3h
15h
3h
Fasted
C57BL6
Fasted
HCHO
Fasted
Ob/ob
Fasted
HCHO
15h
Night
Group1 : C57Bl6 Fasted
Group2 : C57Bl6 Refed
Group3 : ob/ob Fasted
Group4 : ob/ob Refed
O-GlcNAcylated protein levels and FAS expression
C57BL6
Refed
ob/ob
C57BL6
Fasted
17013010070-
WB: O-GlcNAc
55WB: FAS
17055-
***
3
C57
***
Ob/ob
3.5
3
FAS/GAPDH
O-GlcNAc/GAPDH
4
WB: GAPDH
35-
2.5
2
1.5
1
*
FAS ARNm
*
C57
Ob/ob
2.5
2
C57BL6
***
0.45
ob/ob
0.35
1.5
1
0.5
0.5
0.5
0.4
Relative mRNA level
FAS / cyclophilin
Quantification
0.3
0.25
0.2
0.15
*
0.1
0.05
0
0
Fasted
Refed
0
Fasted
Refed
Fasted
Refed
O-GlcNAcylation levels and FAS expression
in physiopathological models
Model 2 : Use of mice C57BL6 fed a chow diet or fed a High Carbohydrate
Diet.
12 weeks
Fasted
Chow Diet (CD)
65% carbohydrate, 24%
protein, 11% fat
Fasted
Fasted
High Carbohydrate Diet (HCD)
75% carbohydrate, 22%
protein, 3% fat
HCHO
Fasted
HCHO
Group1 : CD Fasted
Group2 : CD Refed
Group3 : HCD Fasted
Group4 : HCD Refed
O-GlcNAcylated protein levels and FAS expression
Refed
CD
CD
HCD
Fasted
1701301007055-
WB: O-GlcNAc
WB: FAS
17055-
***
9
CD
6
*
***
8
HCD
0.07
CD
7
NS
6
4
3
CD5
CD
HCD
4
HCD
3
2
2
***
CD
HCD
0.06
HCD
FAS/GAPDH
O-GlcNAc/GAPDH
5
FAS ARNm
Relative mRNA level
FAS / cyclophilin
Quantification
7
WB: GAPDH
35-
0.05
0.04
0.03
NS
0.02
0.01
1
1
0
Fasted
Refed
0
0
Fasted
Refed
Fasted
Refed
Interaction FAS/OGT
Fasted
ob
C57
ob
Refed
Fasted
C57
CD HCD CD
WB: FAS
170-
WB: FAS
Input
130100-
170130-
WB: OGT
100IgG
IgG
170130100-
Input
WB: OGT
WB: FAS
WB: FAS
WB: OGT
Refed
CoIP
OGT
170130100-
FAS and OGT are partners of interaction
CoIP
OGT
WB: OGT
FAS O-GlcNAcylation
 Use of lectins : Wheat Germ Agglutinin
-
+
+
-
HCD
Refed
CD
C57BL6
ob/ob
C57BL6
-
Fasted
-
+ GlcNAc 0.5M
+
-
+
CD
Refed
Fasted
-
+
GlcNAc 0.5M
Input
Input
170-
WB: FAS
WGA beads
170-
170-
170-
WB: FAS
WGA beads
 click chemistry
UDP-GalNAz
UDP
biotin
N3
UDP
Y289L GalT1
N3
Avidinbead
FAS O-GlcNAcylation
 Use of lectins : Wheat Germ Agglutinin
+
-
+
-
HCD
Refed
CD
C57BL6
ob/ob
C57BL6
-
Fasted
-
+ GlcNAc 0.5M
+
-
+
CD
Refed
Fasted
-
GlcNAc 0.5M
Input
Input
170-
+
WB: FAS
WGA beads
170-
WB: FAS
WGA beads
170-
170-
 click chemistry
20-
+
+
GalNAz / biotin alkyne
GalNAz / biotin alkyn
Fasted
Refed
CD HCD
CD
Input
WB: Cristallin
20-
Input
Avidin beads
WB: Avidin-HRP
WB: FAS
Avidin beads
O-GlcNAcylation levels and FAS expression
in physiopathological models
Model 3 : Use of mice C57BL6 presenting an inhibition of OGA
Day 0
Daily injection of PBS/ThiametG
20 mg/ kg/ day
Day 14
Fasted
Fasted
HCHO
Group1 : Fasted
Group2 : Refed
O-GlcNAcylated protein levels and FAS expression
Fasted
ThiametG
PBS
Refed PBS
WB : FAS
130
100
WB : O-GlcNAc
70
50
40
40
WB : GAPDH
35
Quantification
14
FAS ARNm
30
12
**
***
12
6
Relative mRNA level
FAS / cyclophilin
FAS/GAPDH
O-GlcNAc/GAPDH
10
8
8
6
PBS
***
ThiametG
25
10
***
PBS
*
Thiamet-G
4
4
20
15PBS
Thiamet-G
10
NS
5
2
2
0
0
0
Fasted
Refed
Fasted
Refed
Fasted
Refed
 Ex vivo
 Cancer human hepatocytes cell line : HepG2
 Mouse primary hepatocytes cultures
Glc
Fru
Gln
GlcNH2
Gln Glu
Glc
G6P
F6P
GFAT
GlcNH26P
GlcNAc6P
Ser/Thr
ThiametG
NButGT
Mouse primary hepatocytes culture
Expression of FAS
GlcNAc1P
UDP-GlcNAc
OGT
OGA
Ser/Thr
O-GlcNAc
Role of O-GlcNAcylation on FAS stabilisation
HepG2
Kinetic with cycloheximide
CHX + NButGT
CHX
O-GlcNAc
Time (h) 0
S/T
CHX
translation
NButGT
OGA
S/T
1
2
6
14
0
24
1
2
6
14
24
270
WB : FAS
130
100
70
WB : O-GlcNAc
55
PROTEIN
WB : GAPDH
35
Liver mice
Treatment with β-N-acetylglucosaminidase
O-GlcNAc
S/T
kDa
270-
Fasted
Refed
-
-
+
+
Glucosaminidase
WB : FAS
130-
Glucosaminidase
100-
WB : O-GlcNAc
70-
S/T
5535-
WB : GAPDH
Role of O-GlcNAcylation on FAS activity
FAS O-GlcNAcylation
Refed
-
+ GlcNAc 0.5M
CD
C57BL6
+
Refed
HCD
-
+
Fasted
CD
-
ob/ob
C57BL6
Fasted
- +
- +
- +
Input
170-
GlcNAc 0.5M
Input
170WGA beads
170-
WGA beads
170-
WB: FAS
WB: FAS
***
PBS
ThiametG
200
***
10
8
6
4
2
***
µmoles of NAPDH oxydized.
min-1.mg-1 of liver
12
CD
HCD
C57BL6
ob/ob
µmoles of NAPDH oxydized.
min-1.mg-1 of liver
µmoles of NAPDH oxydized.
min-1.mg-1 of liver
FAS activity
0
Fasted
Refed
Fasted
Refed
*
150
100
50
0
Fasted
Refed
Conclusions
FAS regulation :
 by transcription factors
Glucose
Glycolysis
PK
pyruvate
ChREBP
Lipogenesis
ACC, FAS
Fatty acid
SREBP-1c
 by O-GlcNAcylation
 FAS interacts with OGT and it’s O-GlcNAcylated
Roles of the O-GlcNAcylation :
 Increase of global O-GlcNAcylation levels is correlated with an increase
of FAS expression through a reduction of its degradation.
 FAS activity is in correlation with its O-GlcNAcylation
Perspectives
Relation O-GlcNAcylation/ubiquitinylation of FAS
O-GlcNAcylation
Stabilisation
S/T
Phosphorylation
Ubiquitinylation
Degradation
S/T
G5
ø
130100705540170130100-
1704035-
GlcNH2
+
-
+
G25i
-
MG132
WB : O-GlcNAc
• Perform siRNA to silent OGT
WB : ub
• Evaluate FAS ubiquitinylation in function
of O-GlcNAcylation levels
WB : FAS
WB : GAPDH
The MG132 can restore FAS expression at G5 similar to the condition G25. FAS
seems to be degraded by the proteasome in the liver
Team of Pr Tony Lefebvre
Pr Annick Pierce
Dr Ikram El Yazidi
Dr Anne Sophie Vercoutter Edouart
Dr Agata Steenackers
Dr Nao Yamakawa
Moyira Aquino-gil
Maité Leturcq
Anne-Marie Mir
Marlène Mortuaire
Jeanne Vermuse
Collaborations
Céline Guinez (Unité Environnement Périnatal et santé, V d’Ascq)
Catherine Postic (Institut de Cochin, Paris)
Isabelle Hainault (Centre des Cordeliers, Paris)
David Vocadlo (Simon Fraiser University, Burnaby)
Download